e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Anti-inflammatory strategies in acute lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased uric acid levels in bronchoalveolar lavage fluid of mice infected with H1N1 influenza
M. Kuipers, M. Hegeman, H. Aslami, G. Jongsma, C. Wieland, M. Schultz, K. van der Sluijs (Amsterdam, Netherlands)
Source:
Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Session:
Anti-inflammatory strategies in acute lung injury
Session type:
Thematic Poster Session
Number:
809
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Kuipers, M. Hegeman, H. Aslami, G. Jongsma, C. Wieland, M. Schultz, K. van der Sluijs (Amsterdam, Netherlands). Increased uric acid levels in bronchoalveolar lavage fluid of mice infected with H1N1 influenza. Eur Respir J 2011; 38: Suppl. 55, 809
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Excerpts from the upcoming ERS Monograph on COVID-19
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Related content which might interest you:
Comparison of serum and bronchoalveolar lavage fluid sialic acid levels between malignant and benign lung diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 465s
Year: 2002
Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001
Involvement of lymphocytes in
mycoplasma pneumoniae
pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007
High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Serum and bronchoalveolar lavage fluid acute phase reactants and cytokine levels in unilateral community acquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002
Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Blood and BAL T cell cytokine production during RV16 infection in normal and asthmatic human volunteers
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Levels of tumour necrosis factor and interferon in bronchoalveolar lavage fluid and blood serum in children with chronic bronchiolitis
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001
Changes of pneumonia patients bronchoalveolar lavage fluid cellular components
Source: Eur Respir J 2002; 20: Suppl. 38, 471s
Year: 2002
Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
The comparison of bronchoalveolar lavage (BAL) with mini-BAL in pneumonia developed in immunocompromised patients
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Carbocisteine attenuates influenza virus A replication in the bronchoalveolar lavage fluids of virus-infected mice
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Bronchoalveolar lavage amylase levels can be a biomarker of aspiration pneumonia.
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008
Assessment of viral load and time course of pulmonary inflammation in a murine model of H1N1 (PR8) influenza virus infection
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
The role of isoenzymes levels of ‘adenosine deaminase‘ in bronchoalveolar lavage fluid to determining activitiy of pulmonary tuberculosis
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Relationship of viral load in nasal lavage (NL), induced sputum (IS) and bronchoalveolar lavage (BAL) to symptom scores and lung function following experimental rhinovirus (RV) infection in asthmatic and normal human volunteers
Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations
Year: 2004
Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept